- Home
- VIR vs PHK Comparison
VIR vs PHK Comparison
Compare VIR & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- PHK
- Stock Information
- Founded
- VIR 2016
- PHK 2003
- Country
- VIR United States
- PHK United States
- Employees
- VIR N/A
- PHK N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- PHK Finance/Investors Services
- Sector
- VIR Health Care
- PHK Finance
- Exchange
- VIR Nasdaq
- PHK Nasdaq
- Market Cap
- VIR 724.1M
- PHK 765.2M
- IPO Year
- VIR 2019
- PHK N/A
- Fundamental
- Price
- VIR $5.57
- PHK $4.51
- Analyst Decision
- VIR Buy
- PHK
- Analyst Count
- VIR 6
- PHK 0
- Target Price
- VIR $35.67
- PHK N/A
- AVG Volume (30 Days)
- VIR 1.4M
- PHK 491.5K
- Earning Date
- VIR 05-01-2025
- PHK 01-01-0001
- Dividend Yield
- VIR N/A
- PHK 12.61%
- EPS Growth
- VIR N/A
- PHK N/A
- EPS
- VIR N/A
- PHK N/A
- Revenue
- VIR $74,205,000.00
- PHK N/A
- Revenue This Year
- VIR N/A
- PHK N/A
- Revenue Next Year
- VIR $17.69
- PHK N/A
- P/E Ratio
- VIR N/A
- PHK N/A
- Revenue Growth
- VIR N/A
- PHK N/A
- 52 Week Low
- VIR $4.95
- PHK $4.13
- 52 Week High
- VIR $14.45
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- VIR 35.32
- PHK 33.20
- Support Level
- VIR $4.95
- PHK $4.35
- Resistance Level
- VIR $6.02
- PHK $4.73
- Average True Range (ATR)
- VIR 0.48
- PHK 0.13
- MACD
- VIR -0.00
- PHK -0.03
- Stochastic Oscillator
- VIR 29.25
- PHK 45.83
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.